Randomised trial of alternative formulations of oral poliovaccine in Brazil
- PMID: 2893864
- DOI: 10.1016/s0140-6736(88)91229-9
Randomised trial of alternative formulations of oral poliovaccine in Brazil
Abstract
In February to July, 1986, an outbreak of type 3 poliomyelitis occurred in north-east Brazil that was linked to type-specific failure of trivalent oral polio vaccine (TOPV). To see if alternative vaccines would improve seroconversion to type 3, 441 children less than 5 years of age who had previously received no or up to four doses of TOPV were randomly assigned to receive one dose of standard TOPV (1,000,000, 100,000, and 300,000 median tissue culture infection doses [TCID50] of types 1, 2, and 3, respectively); a new formulation of TOPV containing twice the dosage of type 3 (600,000 TCID50); or a monovalent vaccine containing 300,000 TCID50 of type 3. While rates of seroconversion to types 1 or 2 were equivalent following vaccination with either formulation of TOPV, children who received the new formulation were 2.7 times more likely to seroconvert to type 3. Similar differences for type 3 were observed when monovalent vaccine was compared with standard TOPV, though both groups had received the same dose of type 3 antigen. The low rate of seroconversion to type 3 in the standard TOPV group was associated with a higher rate of reinfection with type 2, which also appeared to interfere to some extent with seroconversion to type 1. These findings extend earlier observations that interference from Sabin type 2 virus may be an important contributory cause of type-specific TOPV failure, and suggest that interference can be overcome with alterations in the formulation.
Similar articles
-
Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial.Lancet. 2010 Nov 13;376(9753):1682-8. doi: 10.1016/S0140-6736(10)61230-5. Epub 2010 Oct 25. Lancet. 2010. PMID: 20980048 Clinical Trial.
-
Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial.Hum Vaccin Immunother. 2017 Jun 3;13(6):1-10. doi: 10.1080/21645515.2017.1288769. Epub 2017 Mar 1. Hum Vaccin Immunother. 2017. PMID: 28362135 Free PMC article. Clinical Trial.
-
Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.Bull World Health Organ. 1994;72(2):221-5. Bull World Health Organ. 1994. PMID: 8205641 Free PMC article.
-
Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review.Rev Infect Dis. 1991 Sep-Oct;13(5):926-39. doi: 10.1093/clinids/13.5.926. Rev Infect Dis. 1991. PMID: 1660184 Review.
-
Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication.Clin Infect Dis. 2001 Aug 15;33(4):531-41. doi: 10.1086/321905. Epub 2001 Jul 9. Clin Infect Dis. 2001. PMID: 11462191 Review.
Cited by
-
Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial.Lancet Infect Dis. 2023 Sep;23(9):1062-1071. doi: 10.1016/S1473-3099(23)00139-1. Epub 2023 May 10. Lancet Infect Dis. 2023. PMID: 37178706 Free PMC article. Clinical Trial.
-
Oral polio vaccine response in the MAL-ED birth cohort study: Considerations for polio eradication strategies.Vaccine. 2019 Jan 7;37(2):352-365. doi: 10.1016/j.vaccine.2018.05.080. Epub 2018 Nov 12. Vaccine. 2019. PMID: 30442479 Free PMC article.
-
Historical review of clinical vaccine studies at Oswaldo Cruz Institute and Oswaldo Cruz Foundation--technological development issues.Mem Inst Oswaldo Cruz. 2015 Feb;110(1):114-24. doi: 10.1590/0074-02760140346. Epub 2015 Jan 16. Mem Inst Oswaldo Cruz. 2015. PMID: 25742271 Free PMC article. Review.
-
Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program.J Infect Dis. 2014 Nov 1;210 Suppl 1(0 1):S143-51. doi: 10.1093/infdis/jit588. J Infect Dis. 2014. PMID: 25316829 Free PMC article.
-
History of polio vaccination.World J Virol. 2012 Aug 12;1(4):108-14. doi: 10.5501/wjv.v1.i4.108. World J Virol. 2012. PMID: 24175215 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical